The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

A national HIV testing campaign, organized by the health ministry, is being held for a month, starting from November 11, ...

THERE’S been an “alarming” increase in HIV infections among straight women, a new report warns. It comes as sexual health ...

Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

A PSNI officer has faced months of worry after having blood sprayed into her face by a detainee with suspected HIV. The ...

Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Limako currently serves as a board member at EK FM, where she utilises radio to promote disability awareness and inclusion. She is also the disability coordinator for Positive Convention, promoting ...

In 2017, the Food and Drug Administration approved June’s Chimeric Antigen Receptor T (CAR-T) cell therapy for treating ...